Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/23/23
End: 05/01/25
Due: 05/01/26
Phase: N/A
Priority: Normal
Start: 09/13/22
End: 02/17/23
Due: 02/17/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions | NCT05721729 | Vogenx, Inc. | user2@example.com | None | 2023-06-23 | 2025-05-01 | 2026-05-01 | - | - | 2025-07-14 |
| Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects | NCT05541939 | Vogenx, Inc. | user2@example.com | None | 2022-09-13 | 2023-02-17 | 2024-02-17 | - | - | 2025-07-14 |